Real-world study of intranasal ketamine for use in patients with refractory chronic migraine https://www.medrxiv.org/content/10.1101/2022.11.20.22282558
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.